An intestinal pathogen reshapes the gut environment to fuel its own colonization and cause diseases, a multi-institutional ...

Parkinson's is the second-most common neurodegenerative disease after Alzheimer's. An estimated 1.1 million people in the U.S. have it.

A stem cell-derived intestine model reveals glycyrrhizin as a potential treatment for inflammatory bowel disease.

Oral presentation on the impact of concomitant steroid use in ulcerative colitis (UC) scheduled for May 5, 2026, at 9:30am CDTAUSTIN, Texas, April 29, 2026 (GLOBE NEWSWIRE) -- Cristcot, a ...

For the estimated 5 million people worldwide living with inflammatory bowel disease, finding relief from debilitating symptoms often feels like an endless journey through medication trials and ...

Traditional epidemiological studies have identified numerous potential risk factors, but observational studies have struggled to establish causal links due to confounding factors and reverse causation ...

Alert Pediatric Plaque Psoriasis Treatment Set to Expand in Europe European regulators have recommended expanding use of the IL-23 inhibitor Skyrizi to treat moderate-to-severe plaque psoriasis in ...

Primary care episodes of infectious intestinal disease among individuals in North-West London decreased from 2015 to 2024, whereas hospital admissions rose. The odds of disease-related hospital ...

Recent studies highlight how artificial intelligence and CRISPR-based molecular tools are reshaping gastrointestinal diagnostics, from intestinal tuberculosis to colon polyp detection. AI-assisted ...

University of Houston biologists have contributed to a potential breakthrough in treating Crohn's disease by shifting the ...